ReviewOrphanet journal of rare diseases2025
Unraveling the mystery of alien hand syndrome: when your hand has a mind of its own.
Review in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlien Hand Syndrome (AHS) is a rare neurological disorder characterized by involuntary, complex movements of a limb, often with a sense of estrangement from the affected hand. Initially described in 1908, AHS has since been associated with various neurological conditions, including strokes, neurodegenerative diseases, tumors, and surgical interventions affecting the corpus callosum and frontal lobes.
objectiveThis study aims to provide a comprehensive review of etiology, clinical manifestations, neuroanatomical basis, and differential diagnosis of AHS, synthesizing findings from published case reports and literature.
methodsThis scoping review followed PRISMA-ScR guidelines to systematically analyze AHS case reports from PubMed (2010-2025). Two independent reviewers screened studies using predefined criteria, extracting demographic, clinical, neuroimaging, and treatment data. Eligible case reports required a confirmed AHS diagnosis with complete clinical and neuroimaging documentation. Data synthesis combined descriptive statistics and qualitative analysis to map AHS characteristics across subtypes.
resultsA total of 72 cases were reviewed, with a mean patient age of 59.58 years (SD 18.24), ranging from 9 to 89 years. Males accounted for 48.6% (35 cases), while females represented 51.4% (37 cases). The most frequently implicated brain regions were the corpus callosum, supplementary motor area, and posterior parietal cortex. AHS was commonly associated with stroke, neurodegenerative diseases (e.g., corticobasal syndrome, Creutzfeldt-Jakob disease), and brain tumors. The disorder was categorized into three subtypes, each with distinct clinical presentations and underlying neuropathology. Differential diagnoses included psychiatric disorders, movement disorders, and body schema disturbances.
conclusionAHS remains a rare and complex neurological disorder with diverse etiologies and clinical manifestations. Accurate diagnosis requires thorough clinical evaluation and neuroimaging to differentiate AHS from psychiatric and other neurological conditions. Further research is needed to elucidate its pathophysiology and develop targeted therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.